Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

41.76
-0.4100-0.97%
Post-market: 41.760.00000.00%16:10 EDT
Volume:1.27M
Turnover:52.83M
Market Cap:6.65B
PE:-13.93
High:42.57
Open:42.15
Low:41.25
Close:42.17
Loading ...

U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Beacon Roofing, Liberty Energy

Reuters
·
24 Mar

Ionis Pharmaceuticals: Strategic Partnerships and Financial Flexibility Drive Buy Rating

TIPRANKS
·
17 Mar

Ionis Pharmaceuticals Inc : Leerink Partners Raises Target Price to $55 From $52

THOMSON REUTERS
·
13 Mar

BRIEF-Ionis And Ono Announce Global License Agreement For Sapablursen In Polycythemia Vera

Reuters
·
12 Mar

Ionis and Ono announce global license agreement for sapablursen in polycythemia vera

Business Wire
·
12 Mar

Ionis Pharmaceuticals Is Maintained at Neutral by JP Morgan

Dow Jones
·
11 Mar

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe

Zacks
·
11 Mar

Ionis Pharmaceuticals Says Transthyretin-Mediated Amyloidosis Treatment Gets Approval in Europe

MT Newswires Live
·
10 Mar

BRIEF-WAINZUA (Eplontersen) Approved In The EU For The Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adults With Stage 1 Or Stage 2 Polyneuropathy

Reuters
·
10 Mar

Wainzua (Eplontersen) Approved in the EU for the Treatment of Hereditary Transthyretin-Mediated Amyloidosis in Adults With Stage 1 or Stage 2 Polyneuropathy

THOMSON REUTERS
·
10 Mar

WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy

Business Wire
·
10 Mar

Theratechnologies Inc (THTX) Q4 2024 Earnings Call Highlights: Strong EBITDA Turnaround and ...

GuruFocus.com
·
27 Feb

Ionis to present at upcoming investor conferences

Business Wire
·
25 Feb

The Zacks Analyst Blog Highlights Merck, Sanofi, Regeneron and Ionis

Zacks
·
24 Feb

Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives

TIPRANKS
·
23 Feb

Ionis Pharmaceuticals price target lowered to $60 from $61 at Raymond James

TipRanks
·
21 Feb

Pharma Stock Roundup: EU Nod to MRK's Welireg, IONS' Q4 Results & More

Zacks
·
21 Feb

Ionis Pharmaceuticals Inc : Bernstein Cuts Target Price to $43 From $51

THOMSON REUTERS
·
21 Feb

BRIEF-New Positive Donidalorsen Data To Be Presented At Aaaai/Wao Joint Congress

Reuters
·
20 Feb

New Positive Donidalorsen Data to Be Presented at Aaaai/Wao Joint Congress Highlight Sustained Hae Attack Rate Reduction and Disease Control

THOMSON REUTERS
·
20 Feb